Select a Topic
Pfizer has launched a Phase 3 study of its RSV vaccine candidate and researchers at the George Washington University are studying the vaccine’s…
Julie E. Bauman, MD, MPH, director of the GW Cancer Center, associate dean of cancer and professor of medicine, was featured in the article “Cancer…
The George Washington University Vaccine Research Unit in partnership with Scripps Research, IAVI, Fred Hutchinson Cancer Center (FHCC) and the…
Cold and flu season is upon us, and this year respiratory syncytial virus, or RSV, has joined the COVID-19 variants as complicating factors. Learn…
The GW School of Medicine and Health Sciences is recruiting participants for the final stage of a clinical trial to evaluate two Omicron-specific…
Two D.C.-area facilities are recruiting volunteers to test the efficacy of different doses of a monkeypox vaccine with the hope that they can stretch…
Following the completion of its grant from the D.C. Department of Health, the George Washington University (GW) Medical Faculty Associates (MFA)…
The GW School of Medicine and Health Sciences has been selected to serve as one of 24 participating sites for the Phase 2 clinical trial to evaluate…
David Diemert, MD, clinical director of the GW Vaccine Research Unit and professor of medicine at the George Washington University School of Medicine…
A vaccine for Lassa fever may be on the horizon, thanks to a new clinical trial jointly led by Elissa Malkin, DO, MPH, assistant research professor…